ArticleFrontiers in immunology2026
Gut microbiota transfer from autoimmune dry eye mice imprints stereotypic B cell receptor repertoires in the lacrimal gland and induces disease.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gut microbiota and humoral immunity have been suggested as key players in the pathogenesis of Sjögren disease (SjD), but their mechanisms remain unclear. In this study, we transferred the gut microbiota of SjD-like autoimmune dry eye disease model mice to B6 mice, then characterized the resulting gut microbiome composition, clinical ocular phenotype, and B cell receptor (BCR) repertoire. Notable changes were observed in the gut microbiome of NOD-FMT mice, accompanied by SjD-like clinical features, including elevated corneal fluorescein staining scores, reduced tear production, increased IL-6 mRNA levels, and decreased MUC5AC mRNA levels. Additionally, stereotypic B cell receptor (BCR) clonotypes were shared at significantly higher frequencies in NOD-FMT mice than in controls. The majority of B cell clones encoding these stereotypic clonotypes developed and expanded locally in the lacrimal gland, and some also achieved systemic presence. These results uncover a gut-ocular immune axis in which microbiota transfer induces stereotyped, systemically disseminating BCR clonotypes that contribute to the immunopathogenesis of autoimmune dry eye disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.